DANVITAL ApS: Financial statements 2018
CVR: 34595062
DANVITAL ApS (CVR 34595062) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -16,701 and a net result of DKK -24,040 compared with DKK -17,655 the year before. Equity amounted to DKK 9,350. The solvency ratio was 48.3%.
- Gross Profit
- -16,701 kr.
- Profit/Loss
- -24,040 kr.
- Equity
- 9,350 kr.
- Total Assets
- 19,343 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -17 t. | -24 t. | 9 t. | - |
| 2017 | - | -24 t. | -18 t. | 33 t. | - |
| 2016 | - | -14 t. | -9 t. | 51 t. | - |
| 2015 | - | -17 t. | -11 t. | 60 t. | - |
| 2014 | - | 8 t. | 9 t. | 70 t. | - |
Keep an eye on DANVITAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
DANVITAL ApS has published its annual report for 2017. Gross profit came to DKK -24,084, and the net result was DKK -17,655.
About DANVITAL ApS
DANVITAL ApS was a Danish company of the type Anpartsselskab based in Svendborg, founded in 2012 and dissolved in 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -19,790 and a net result of DKK -19,803 compared with DKK -32,749 the year before. Equity amounted to DKK -43,202.
